Table 4. Linear Associations Between Clinical/Demographic Characteristics and ASC and Interleukin-1β.
N=54 | ASC | IL-1β | |
---|---|---|---|
| |||
ASC | Pearson's r | 1 | -.443** |
Sig. (2-tailed) | - | .001 | |
| |||
IL-1β | Pearson's r | -.443** | 1 |
Sig. (2-tailed) | .001 | - | |
| |||
Age | Pearson's r | .059 | -.026 |
Sig. (2-tailed) | .691 | .849 | |
| |||
Female | Pearson's r | -.042 | .240 |
Sig. (2-tailed) | .813 | .081 | |
| |||
AA/Black | Pearson's r | -.188 | .218 |
Sig. (2-tailed) | .213 | .114 | |
| |||
BMI | Pearson's r | -.048 | .111 |
Sig. (2-tailed) | .732 | .425 | |
| |||
β-blocker | Pearson's r | -.03 | .006 |
Sig. (2-tailed) | .841 | .966 | |
| |||
ACEi | Pearson's r | -.227 | .031 |
Sig. (2-tailed) | .138 | .843 | |
| |||
ARB | Pearson's r | -.038 | -.066 |
Sig. (2-tailed) | .811 | .679 | |
| |||
Diuretic | Pearson's r | -.160 | .096 |
Sig. (2-tailed) | .273 | .514 | |
| |||
Pacer/ICD | Pearson's r | -.131 | .028 |
Sig. (2-tailed) | .322 | .844 | |
| |||
Hypertension | Pearson's r | -.222 | .156 |
Sig. (2-tailed) | .107 | .260 | |
| |||
Dyslipidemia | Pearson's r | .123 | -.156 |
Sig. (2-tailed) | .374 | .259 | |
| |||
Depression | Pearson's r | .098 | -.161 |
Sig. (2-tailed) | .479 | .245 | |
| |||
Diabetes Mellitus | Pearson's r | -.200 | .028 |
Sig. (2-tailed) | .147 | .839 | |
| |||
Previous MI | Pearson's r | -.063 | -.204 |
Sig. (2-tailed) | .648 | .140 |
ASC = apoptosis associated speck-like protein with a caspase recruitment domain
IL = interleukin
AA = African American
BMI = Body mass index
ACEi = Angiotensin converting enzyme inhibitor
ARB = Angiotensin receptor blocker
ICD = Implantable cardioverter defibrillator
MI = Myocardial Infarction
Significant (sig.) at p<.05 using 2-tailed bivariate Pearson correlation analysis.